Endothelial Replacement and Angiogenesis in Arteriosclerotic Lesions of Allografts Are Contributed by Circulating Progenitor Cells

Circulation

Volumn 108, Issue 25, 2003, Pages 3122-3127

  Hu, Yanhua ^a   Davison, Fergus ^a   Zhang, Zhongyi ^a   Xu, Qingbo ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Angiogenesis; Arteriosclerosis; Endothelium; Lesion; Transplantation

Indexed keywords

BETA GALACTOSIDASE;

ADVENTITIA; ALLOGRAFT; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA GRAFT; ARTERIOSCLEROSIS; ARTERY INTIMA; ARTERY LESION; ARTICLE; BONE MARROW; CELL REGENERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; MICROVASCULATURE; NONHUMAN; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; STEM CELL; TRANSGENIC MOUSE;

ANIMALS; AORTA; ARTERIES; ARTERIOSCLEROSIS; BONE MARROW CELLS; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICROCIRCULATION; NEOVASCULARIZATION, PATHOLOGIC; REGENERATION; STEM CELLS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0346788541     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000105722.96112.67     Document Type: Article

References (35)

1. Weis M, von Scheidt W. Cardiac allograft vasculopathy: a review. Circulation. 1997;96:2069-2077.
2. Libby P, Pober JS. Chronic rejection. Immunity. 2001;14:387-397.
3. Ip JH, Fuster V, Badimon L, et al. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol. 1990;15:1667-1687.
4. Bieber CP, Stinson EB, Shumway NE, et al. Cardiac transplantation in man, VII: cardiac allograft pathology. Circulation. 1970;41:753-772.
5. Bohle A, Fischbach H. [Further findings on adaptation of transplants of human kidneys]. Virchows Arch A Pathol Pathol Anat. 1970;349:170-178.
6. Yousem SA, Sonmez-Alpan E. Use of a biotinylated DNA probe specific for the human Y chromosome in the evaluation of the allograft lung. Chest. 1991;99:275-279.
7. Hruban RH, Long PP, Perlman EJ, et al. Fluorescence in situ hybridization for the Y-chromosome can be used to detect cells of recipient origin in allografted hearts following cardiac transplantation. Am J Pathol. 1993;142:975-980.
8. Hillebrands JL, Klatter FA, Rozing J. Origin of vascular smooth muscle cells and the role of circulating stem cells in transplant arteriosclerosis. Arterioscler Thromb Vasc Biol. 2003;23:380-387.
9. Hillebrands JL, Klatter FA, van den Hurk BM, et al. Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis. J Clin Invest. 2001;107:1411-1422.
10. Hu Y, Davison F, Ludewig B, et al. Smooth muscle cells in transplant atherosclerotic lesions are originated from recipients, but not bone marrow progenitor cells. Circulation. 2002;106:1834-1839.
11. Lagaaij EL, Cramer-Knijnenburg GF, van Kemenade FJ, et al. Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet. 2001;357:33-37.
12. Libby P, Zhao DX. Allograft arteriosclerosis and immune-driven angiogenesis. Circulation. 2003;107:1237-1239.
13. Lemstrom KB, Krebs R, Nykanen AI, et al. Vascular endothelial growth factor enhances cardiac allograft arteriosclerosis. Circulation. 2002;105:2524-2530.
14. Kahlon R, Shapero J, Gotlieb AI. Angiogenesis in atherosclerosis. Can J Cardiol. 1992;8:60-64.
15. Moulton KS. Plaque angiogenesis and atherosclerosis. Curr Atheroscler Rep. 2001;3:225-233.
16. Nykanen AI, Krebs R, Saaristo A, et al. Angiopoietin-1 protects against the development of cardiac allograft arteriosclerosis. Circulation. 2003;107:1308-1314.
17. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999;85:221-228.
18. Yamashita J, Itoh H, Hirashima M, et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature. 2000;408:92-96.
19. Gunsilius E, Duba HC, Petzer AL, et al. Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet. 2000;355:1688-1691.
20. Reyes M, Dudek A, Jahagirdar B, et al. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest. 2002;109:337-346.
21. Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet. 2002;360:427-435.
22. Dietrich H, Hu Y, Zou Y, et al. Mouse model of transplant arteriosclerosis: role of intercellular adhesion molecule-1. Arterioscler Thromb Vasc Biol. 2000;20:343-352.
23. Schlaeger TM, Bartunkova S, Lawitts JA, et al. Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice. Proc Natl Acad Sci U S A. 1997;94:3058-3063.
24. Seitz CS, Kleindienst R, Xu Q, et al. Coexpression of heat-shock protein 60 and intercellular-adhesion molecule-1 is related to increased adhesion of monocytes and T cells to aortic endothelium of rats in response to endotoxin. Lab Invest. 1996;74:241-252.
25. Zou Y, Hu Y, Mayr M, et al. Reduced neointima hyperplasia of vein bypass grafts in intercellular adhesion molecule-1-deficient mice. Circ Res. 2000;86:434-440.
26. Hu Y, Baker AH, Zou Y, et al. Local gene transfer of tissue inhibitor of metalloproteinase-2 influences vein graft remodeling in a mouse model. Arterioscler Thromb Vasc Biol. 2001;21:1275-1280.
27. Hu Y, Mayr M, Metzler B, et al. Both donor and recipient origins of smooth muscle cells in vein graft atherosclerotic lesions. Circ Res. 2002;91:e13-e20.
28. Mayr U, Mayr M, Li C, et al. Loss of p53 accelerates neointimal lesions of vein bypass grafts in mice. Circ Res. 2002;90:197-204.
29. Meckel CR, Anderson TJ, Mudge GH, et al. Hemostatic/fibrinolytic predictors of allograft coronary artery disease after cardiac transplantation. Vasc Med. 1997;2:306-312.
30. Hillebrands JL, Klatter FA, van Dijk WD, Rozing J. Bone marrow does not contribute substantially to endothelial-cell replacement in transplant arteriosclerosis. Nat Med. 2002;8:194-195.
31. Hasina R, Lingen MW. Angiogenesis in oral cancer. J Dent Educ. 2001;65:1282-1290.
32. Ross JS, Stagliano NE, Donovan MJ, et al. Atherosclerosis and cancer: common molecular pathways of disease development and progression. Ann N Y Acad Sci. 2001;947:271-293.
33. Kockx MM, Cromheeke KM, Knaapen MW, et al. Phagocytosis and macrophage activation associated with hemorrhagic microvessels in human atherosclerosis. Arterioscler Thromb Vasc Biol. 2003;23:440-446.
34. O'Brien JE Jr, Shi Y, Fard A, et al. Wound healing around and within saphenous vein bypass grafts. J Thorac Cardiovasc Surg. 1997;114:38-45.
35. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest. 2000;105:71-77.